Phibro Animal Health (PAHC) Cash & Current Investments (2013 - 2026)

Phibro Animal Health's Cash & Current Investments history runs 14 years deep, the most recent figure standing at $77.5 million for Q1 2026.

• On a quarterly basis, Cash & Current Investments rose 10.09% year-over-year to $77.5 million in Q1 2026; TTM through Mar 2026 was $77.5 million, a 10.09% increase from a year earlier, with the FY2025 full-year figure at $77.0 million, down 32.78% from the prior year.
• Cash & Current Investments improved to $77.5 million in Q1 2026 per PAHC's latest filing, from $74.5 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $114.6 million in Q2 2024 and bottomed at $67.1 million in Q4 2024.
• The 5-year median for Cash & Current Investments is $85.3 million (2025), against an average of $85.1 million.
• Across the five-year window, Cash & Current Investments soared 41.01% in 2024 and tumbled 32.78% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $78.4 million in 2022, then rose by 17.94% to $92.5 million in 2023, then dropped by 27.48% to $67.1 million in 2024, then increased by 11.08% to $74.5 million in 2025, then rose by 3.95% to $77.5 million in 2026.
• Per Business Quant, the three latest PAHC Cash & Current Investments figures stand at $77.5 million (Q1 2026), $74.5 million (Q4 2025), and $85.3 million (Q3 2025).